AU2026900A - Neuron stimulation by ribavirin, and analogs thereof - Google Patents

Neuron stimulation by ribavirin, and analogs thereof

Info

Publication number
AU2026900A
AU2026900A AU20269/00A AU2026900A AU2026900A AU 2026900 A AU2026900 A AU 2026900A AU 20269/00 A AU20269/00 A AU 20269/00A AU 2026900 A AU2026900 A AU 2026900A AU 2026900 A AU2026900 A AU 2026900A
Authority
AU
Australia
Prior art keywords
ribavirin
analogs
neuron stimulation
neuron
stimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20269/00A
Inventor
Fred Harrison Gage
Roger C. L. Guillemin
Jasodhara Ray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of AU2026900A publication Critical patent/AU2026900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU20269/00A 1998-11-20 1999-11-19 Neuron stimulation by ribavirin, and analogs thereof Abandoned AU2026900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10930898P 1998-11-20 1998-11-20
US60109308 1998-11-20
PCT/US1999/027475 WO2000030656A1 (en) 1998-11-20 1999-11-19 Neuron stimulation by ribavirin, and analogs thereof

Publications (1)

Publication Number Publication Date
AU2026900A true AU2026900A (en) 2000-06-13

Family

ID=22326980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20269/00A Abandoned AU2026900A (en) 1998-11-20 1999-11-19 Neuron stimulation by ribavirin, and analogs thereof

Country Status (2)

Country Link
AU (1) AU2026900A (en)
WO (1) WO2000030656A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK8612002A3 (en) * 1999-12-23 2003-03-04 Ribapharm Inc Compositions and methods for L-nucleosides, L-nucleotides, and their analogs
JP2005524662A (en) * 2002-02-28 2005-08-18 ビオタ インコーポレーティッド Nucleoside 5'-monophosphate mimetics and their prodrugs
CN1761471A (en) * 2003-02-25 2006-04-19 应用研究系统Ars股份公司 Combined use of ribavirin and interferon beta in demyelinating diseases
AU2007299726A1 (en) * 2006-09-22 2008-03-27 Braincells, Inc. Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis
CN102558261A (en) * 2010-12-17 2012-07-11 中国科学院大连化学物理研究所 Nucleotide analogue and synthesis and application thereof
CN105412137B (en) * 2015-11-30 2018-06-05 李慧 Ribavirin is used to prepare the application of ischemia apoplexy medicine
WO2018102672A1 (en) 2016-12-04 2018-06-07 Alavi Khorassani Moghadam Marcel Victor Methods for treating diseases related to mitochondrial stress
US11993590B2 (en) 2016-12-04 2024-05-28 712 North Inc. Pyranone compounds useful to modulate OMA1 protease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
EP0262125B1 (en) * 1986-03-27 1996-03-27 Gensia, Inc. AICA riboside for the prophylactic treatment of diseases with restricted blood flow.
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
DE4307883A1 (en) * 1992-03-12 1993-09-23 Westarp Martin Egon Dr Med Use of anti-retroviral substances - to treat motor-neuronal diseases
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes

Also Published As

Publication number Publication date
WO2000030656A1 (en) 2000-06-02
WO2000030656A9 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU1464900A (en) Independent elliptical motion exerciser
ZA200006312B (en) Antibodies to CD23, derivatives thereof, and their therapeutic uses.
HU9600732D0 (en) Cyclic compounds, their production and use
AU5130299A (en) Wrist-mounted i.v. administration set
ZA991568B (en) Arylphenyl-substituted cyclic ketoenols.
AU4873496A (en) Drag reducing arrangement for athlete
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU1344400A (en) Inflammation-associated genes
AU5902199A (en) Exercise device
AU4328299A (en) Human diet supplement
AU1772399A (en) Well treatment
AU6511698A (en) Exercise devices
AU2026900A (en) Neuron stimulation by ribavirin, and analogs thereof
AU5799596A (en) Electrochemical light-emitting devices
PL326837A1 (en) 25-hydroxy-16-ene-26, 27-bishomocholecarctiferoles
AU1541399A (en) Human nucleotide pyrophosphohydrolase-2
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU2227999A (en) Human ependymin
AU1968200A (en) Pesticide treatment
AU5472899A (en) Human angiopoietin-3
AU8155898A (en) Human preprotachykinin b
AU1645599A (en) Human matrilin-3
AUPP099297A0 (en) Animal exerciser
AU3836399A (en) An exercise garment
AU4992099A (en) Human presenilin-associated protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase